Czechia, April 15 -- Czechia based Gilead Sciences s.r.o. has secured contract from Krajska zdravotni, a.s. for Antineoplastic agents Supplies of medicinal preparations with the active substance SACITUZUMAB GOVITECAN. The value of the contract is worth 923144000 CZK.
Published by HT Digital Content Services with permission from Pivotal Sources....